{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:17:16Z","timestamp":1784809036202,"version":"3.55.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"am","delay-in-days":327,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["N\\u00B0 956"],"award-info":[{"award-number":["N\\u00B0 956"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation","doi-asserted-by":"publisher","award":["97003540"],"award-info":[{"award-number":["97003540"]}],"id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008257","name":"Tarbiat Modares University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.exppara.2021.108082","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T20:16:24Z","timestamp":1612988184000},"page":"108082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Evaluation of protection induced by in vitro maturated BMDCs presenting CD8+ T cell stimulating peptides after a heterologous vaccination regimen in BALB\/c model against Leishmania major"],"prefix":"10.1016","volume":"223","author":[{"given":"Atefeh Sadeghi","family":"Shermeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Zahedifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Habibzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahereh","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Rafati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Seyed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"31","key":"10.1016\/j.exppara.2021.108082_bib1","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1016\/j.vaccine.2011.04.089","article-title":"Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis","volume":"29","author":"Agallou","year":"2011","journal-title":"Vaccine"},{"issue":"34","key":"10.1016\/j.exppara.2021.108082_bib2","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1016\/j.vaccine.2012.05.075","article-title":"Vaccination with Leishmania histone H1-pulsed dendritic cells confers protection in murine visceral leishmaniasis","volume":"30","author":"Agallou","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.exppara.2021.108082_bib3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3389\/fimmu.2014.00268","article-title":"Experimental validation of multi-epitope peptides including promising MHC class I- and II-restricted epitopes of four known Leishmania infantum proteins","volume":"5","author":"Agallou","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.exppara.2021.108082_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molimm.2018.08.004","article-title":"Induction of protective cellular immune responses against experimental visceral leishmaniasis mediated by dendritic cells pulsed with the N-terminal domain of Leishmania infantum elongation factor-2 and CpG oligodeoxynucleotides","volume":"103","author":"Agallou","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.exppara.2021.108082_bib5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fimmu.2017.00100","article-title":"A chimera containing CD4+ and CD8+ T-cell epitopes of the Leishmania donovani nucleoside hydrolase (NH36) optimizes cross-protection against Leishmania amazonesis infection","volume":"8","author":"Alves-Silva","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.exppara.2021.108082_bib6","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3389\/fimmu.2017.00684","volume":"8","author":"Athanasiou","year":"2017","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.exppara.2021.108082_bib7","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.4049\/jimmunol.168.8.3992","article-title":"CD8+ T cells are required for primary immunity in C57BL\/6 mice following low-dose, intradermal challenge with Leishmania major","volume":"168","author":"Belkaid","year":"2002","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.exppara.2021.108082_bib8","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.micinf.2007.02.018","article-title":"Adoptive transfer of dendritic cells pulsed with Leishmania infantum nucleosomal histones confers protection against cutaneous leishmaniosis in BALB\/c mice","volume":"9","author":"Carrion","year":"2007","journal-title":"Microb. Infect."},{"issue":"3","key":"10.1016\/j.exppara.2021.108082_bib9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00262-011-1110-7","article-title":"Design of immunogenic and effective multi-epitope DNA vaccines for melanoma","volume":"61","author":"Cho","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"issue":"4","key":"10.1016\/j.exppara.2021.108082_bib10","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1038\/cti.2015.6","article-title":"From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE","volume":"4","author":"Coler","year":"2015","journal-title":"Clin Transl Immunology"},{"issue":"234","key":"10.1016\/j.exppara.2021.108082_bib11","doi-asserted-by":"crossref","first-page":"234ra56","DOI":"10.1126\/scitranslmed.3008222","article-title":"Modular multiantigen T cell epitope-enriched DNA vaccine against human leishmaniasis","volume":"6","author":"Das","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.exppara.2021.108082_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007939","article-title":"Lactococcus lactis expressing sand fly PpSP15 salivary protein confers long-term protection against Leishmania major in BALB\/c mice","volume":"14","author":"Davarpanah","year":"2020","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2021.108082_bib13","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3389\/fimmu.2018.01043","article-title":"Peptide vaccines for leishmaniasis","volume":"9","author":"De Brito","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.exppara.2021.108082_bib14","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/jcb.26190","article-title":"Mining the proteome of Leishmania donovani for the development of novel MHC class I restricted epitope for the control of visceral leishmaniasis","volume":"119","author":"Dikhit","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.exppara.2021.108082_bib15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jconrel.2011.04.011","article-title":"Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection","volume":"153","author":"Doroud","year":"2011","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.exppara.2021.108082_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.coi.2003.11.007","article-title":"Activation of dendritic cells: translating innate into adaptive immunity","volume":"16","author":"e Sousa","year":"2004","journal-title":"Curr. Opin. Immunol."},{"issue":"1","key":"10.1016\/j.exppara.2021.108082_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2217\/imt.14.102","article-title":"Leishmania infantum FML pulsed-dendritic cells induce a protective immune response in murine visceral leishmaniasis","volume":"7","author":"Foroughi-Parvar","year":"2015","journal-title":"Immunotherapy"},{"issue":"7","key":"10.1016\/j.exppara.2021.108082_bib18","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1128\/CVI.05024-11","article-title":"KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis","volume":"18","author":"Goto","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"issue":"16","key":"10.1016\/j.exppara.2021.108082_bib19","doi-asserted-by":"crossref","first-page":"9305","DOI":"10.1073\/pnas.96.16.9305","article-title":"CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells","volume":"96","author":"Hartmann","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11\u201312","key":"10.1016\/j.exppara.2021.108082_bib20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.0141-9838.2004.00668.x","article-title":"Cross-talk between CD8(+) and CD4(+) T cells in experimental cutaneous leishmaniasis: CD8(+) T cells are required for optimal IFN-gamma production by CD4(+) T cells","volume":"25","author":"Herath","year":"2003","journal-title":"Parasite Immunol."},{"issue":"5","key":"10.1016\/j.exppara.2021.108082_bib21","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/pmic.200800533","article-title":"Mining the Leishmania genome for novel antigens and vaccine candidates","volume":"9","author":"Herrera-Najera","year":"2009","journal-title":"Proteomics"},{"issue":"6","key":"10.1016\/j.exppara.2021.108082_bib22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.pt.2019.04.002","article-title":"CD4(+) T cell-mediated immunity against the phagosomal pathogen Leishmania: implications for vaccination","volume":"35","author":"Hohman","year":"2019","journal-title":"Trends Parasitol."},{"issue":"10\u201311","key":"10.1016\/j.exppara.2021.108082_bib23","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.micinf.2008.06.002","article-title":"Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in mice","volume":"10","author":"Iborra","year":"2008","journal-title":"Microb. Infect."},{"issue":"5733","key":"10.1016\/j.exppara.2021.108082_bib24","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.1112680","article-title":"The genome of the kinetoplastid parasite, Leishmania major","volume":"309","author":"Ivens","year":"2005","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.exppara.2021.108082_bib25","doi-asserted-by":"crossref","first-page":"ftw041","DOI":"10.1093\/femspd\/ftw041","article-title":"SLA-PGN-primed dendritic cell-based vaccination induces Th17-mediated protective immunity against experimental visceral leishmaniasis: a crucial role of PKC\u00ce2","volume":"74","author":"Jawed","year":"2016","journal-title":"FEMS Pathogens and Disease"},{"issue":"2 Pt B","key":"10.1016\/j.exppara.2021.108082_bib26","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.molimm.2015.08.001","article-title":"Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB\/c mice model","volume":"67","author":"Katebi","year":"2015","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.exppara.2021.108082_bib27","doi-asserted-by":"crossref","first-page":"8285","DOI":"10.1038\/s41598-017-08842-w","article-title":"Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach","volume":"7","author":"Khatoon","year":"2017","journal-title":"Sci. Rep."},{"issue":"45","key":"10.1016\/j.exppara.2021.108082_bib28","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1016\/j.vaccine.2010.08.079","article-title":"DNA vaccine with alpha-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cells","volume":"28","author":"Kim","year":"2010","journal-title":"Vaccine"},{"issue":"3\u20134","key":"10.1016\/j.exppara.2021.108082_bib29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/08830180600743057","article-title":"Adjuvant activity of CpG oligodeoxynucleotides","volume":"25","author":"Klinman","year":"2006","journal-title":"Int. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.exppara.2021.108082_bib30","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1073\/pnas.93.7.2879","article-title":"CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma","volume":"93","author":"Klinman","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.exppara.2021.108082_bib31","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1080\/21645515.2015.1020265","article-title":"DNA is an efficient booster of dendritic cell-based vaccine","volume":"11","author":"Li","year":"2015","journal-title":"Hum. Vaccines Immunother."},{"issue":"1","key":"10.1016\/j.exppara.2021.108082_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","article-title":"An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow","volume":"223","author":"Lutz","year":"1999","journal-title":"J. Immunol. Methods"},{"issue":"11","key":"10.1016\/j.exppara.2021.108082_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048727","article-title":"CXCL10 is critical for the generation of protective CD8 T cell response induced by antigen pulsed CpG-ODN activated dendritic cells","volume":"7","author":"Majumder","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.exppara.2021.108082_bib34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fimmu.2014.00261","article-title":"Antigen-pulsed CpG-ODN-activated dendritic cells induce host-protective immune response by regulating the T regulatory cell functioning in Leishmania donovani-infected mice: critical role of CXCL10","volume":"5","author":"Majumder","year":"2014","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.exppara.2021.108082_bib35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00005-017-0484-4","article-title":"Comparative assessment of induced immune responses following intramuscular immunization with fusion and cocktail of LeIF, LACK and TSA genes against cutaneous leishmaniasis in BALB\/c mice","volume":"66","author":"Maspi","year":"2018","journal-title":"Arch. Immunol. Ther. Exp."},{"issue":"6","key":"10.1016\/j.exppara.2021.108082_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067453","article-title":"Targeting Leishmania major antigens to dendritic cells in vivo induces protective immunity","volume":"8","author":"Matos","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.exppara.2021.108082_bib37","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/978-1-4615-1971-3_114","article-title":"Dendritic cells seclude Leishmania parasites that persist in cured mice--a role in the maintenance of T-cell memory?","volume":"378","author":"Moll","year":"1995","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.exppara.2021.108082_bib38","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/eji.1830250310","article-title":"Dendritic cells in Leishmania major\u2010immune mice harbor persistent parasites and mediate an antigen\u2010specific T cell immune response","volume":"25","author":"Moll","year":"1995","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.exppara.2021.108082_bib39","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijpharm.2017.09.055","article-title":"Skin vaccination using microneedles coated with a plasmid DNA cocktail encoding nucleosomal histones of Leishmania spp","volume":"533","author":"Moreno","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.exppara.2021.108082_bib40","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.4049\/jimmunol.1202183","article-title":"CD4+ T cell persistence and function after infection are maintained by low-level peptide: MHC class II presentation","volume":"190","author":"Nelson","year":"2013","journal-title":"J. Immunol."},{"issue":"25\u201326","key":"10.1016\/j.exppara.2021.108082_bib41","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1016\/S0264-410X(01)00081-0","article-title":"A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major","volume":"19","author":"Rafati","year":"2001","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.exppara.2021.108082_bib42","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.4049\/jimmunol.172.10.6281","article-title":"Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC","volume":"172","author":"Ramirez-Pineda","year":"2004","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.exppara.2021.108082_bib43","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.exppara.2021.108082_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007880","article-title":"Immunogenicity and efficacy of single antigen Gp63, polytope and polytopeHSP70 DNA vaccines against visceral Leishmaniasis in experimental mouse model","volume":"4","author":"Sachdeva","year":"2009","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.exppara.2021.108082_bib45","first-page":"325","article-title":"Optimization of the timing of induction for the assessment of nitric oxide production in Leishmania major infected macrophage cells","volume":"11","author":"Sadeghi","year":"2016","journal-title":"Iran. J. Parasitol."},{"issue":"12","key":"10.1016\/j.exppara.2021.108082_bib46","first-page":"1493","article-title":"Immunization against Leishmania major infection in BALB\/c mice using a subunit-based DNA vaccine derived from TSA, LmSTI1, KMP11, and LACK predominant antigens","volume":"22","author":"Salehi-Sangani","year":"2019","journal-title":"Iran J Basic Med Sci"},{"issue":"4","key":"10.1016\/j.exppara.2021.108082_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002174","article-title":"Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis","volume":"7","author":"Saljoughian","year":"2013","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"6","key":"10.1016\/j.exppara.2021.108082_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003476","article-title":"T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine","volume":"9","author":"Schwarz","year":"2013","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.exppara.2021.108082_bib49","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.0105-2896.2004.00198.x","article-title":"The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development","volume":"201","author":"Scott","year":"2004","journal-title":"Immunol. Rev."},{"issue":"9","key":"10.1016\/j.exppara.2021.108082_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001295","article-title":"Silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell response","volume":"5","author":"Seyed","year":"2011","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"10","key":"10.1016\/j.exppara.2021.108082_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108848","article-title":"Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2\/DR1 transgenic mice: steps toward polytope vaccine","volume":"9","author":"Seyed","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.exppara.2021.108082_bib52","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3389\/fmicb.2016.00467","article-title":"Post-genomics and vaccine improvement for Leishmania","volume":"7","author":"Seyed","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.exppara.2021.108082_bib53","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3389\/fimmu.2018.01227","article-title":"Translating observations from leishmanization into non-living vaccines: the potential of dendritic cell-based vaccination strategies against Leishmania","volume":"9","author":"Seyed","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.exppara.2021.108082_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008574","article-title":"Dendritic cell mediated delivery of plasmid DNA encoding LAMP\/HIV-1 Gag fusion immunogen enhances T cell epitope responses in HLA DR4 transgenic mice","volume":"5","author":"Simon","year":"2010","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.exppara.2021.108082_bib55","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1039\/C5SC03892H","article-title":"Peptide-based synthetic vaccines","volume":"7","author":"Skwarczynski","year":"2016","journal-title":"Chem. Sci."},{"issue":"4","key":"10.1016\/j.exppara.2021.108082_bib56","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.4049\/jimmunol.175.4.2517","article-title":"IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection","volume":"175","author":"Stober","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.exppara.2021.108082_bib57","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fimmu.2019.00227","article-title":"Molecular aspects of dendritic cell activation in leishmaniasis: an immunobiological view","volume":"10","author":"Tiburcio","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.exppara.2021.108082_bib58","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/039463200401700314","article-title":"Dendritic cells pulsed with peptides of gp63 induce differential protection against experimental cutaneous leishmaniasis","volume":"17","author":"Tsagozis","year":"2004","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"9","key":"10.1016\/j.exppara.2021.108082_bib59","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1002\/eji.201040484","article-title":"A live Leishmania major vaccine containing CpG motifs induces the de novo generation of Th17 cells in C57BL\/6 mice","volume":"40","author":"Wu","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"15\u201316","key":"10.1016\/j.exppara.2021.108082_bib60","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.vaccine.2003.11.014","article-title":"Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis","volume":"22","author":"Zadeh-Vakili","year":"2004","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.exppara.2021.108082_bib61","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4172\/1948-5948.1000250","article-title":"Assessment of protection induced by DNA and live vaccine encoding Leishmania MHC class I restricted epitopes against L. major challenge in Balb\/c mice model","volume":"7","author":"Zandieh","year":"2015","journal-title":"J. Microb. Biochem. Technol."},{"issue":"3","key":"10.1016\/j.exppara.2021.108082_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230381","article-title":"The immunogenicity and protective immunity of multi-epitopes DNA prime-protein boost vaccines encoding Amastin-Kmp-11, Kmp11-Gp63 and Amastin-Gp63 against visceral leishmaniasis","volume":"15","author":"Zhang","year":"2020","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.exppara.2021.108082_bib63","article-title":"Anti-leishmanial vaccines: assumptions, approaches, and annulments","volume":"7","author":"Zutshi","year":"2019","journal-title":"Vaccines (Basel)"}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489421000199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489421000199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:49:12Z","timestamp":1777391352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489421000199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":63,"alternative-id":["S0014489421000199"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2021.108082","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of protection induced by in vitro maturated BMDCs presenting CD8+ T cell stimulating peptides after a heterologous vaccination regimen in BALB\/c model against Leishmania major","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2021.108082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108082"}}